23 Oct 2019

Hot topics in HIV: Vaccines, Immune Recovery and Eradication 2019

HIV
On-site
English
Palau Macaya, Barcelona

Status

Activity finished

Price

Free

Do you want to know the next activities activities?

Information

The yearly conference on Hot topics in HIV remission responds to the need of providing an update on these issues, which have a direct impact on the current treatment strategies: importance of early diagnosis, suitability of the early start of treatment, identification of patients newly infected with higher likelihood of benefiting from curative treatments.

HIV infection remains a major public health threat worldwide. Around 37 million people are living with HIV and only 21.7 million were accessing antiretroviral treatment in 2017. Since the start of the epidemic 77.3 million have become infected and 35.4 million have died from AIDS-related illness. There are 1.7 million new HIV infections every year and it is estimated that 75% of the people living with HIV know their status, among those 79% are accessing treatment and 81% of those accessing treatment are virally suppressed.

Program:

Download program

Coordinators

Bonaventura Clotet

President of the Fight Infections Foundation and Director of IrsiCaixa

Fight Infections Foundation. IrsiCaixa AIDS Research Institute and Catalan Institute of Health, Badalona, Spain

Bonaventura Clotet

President of the Fight Infections Foundation and Director of IrsiCaixa

Dr. Clotet received his MD (1976) and his PhD (1981), with a thesis on autoimmune diseases, from the Autonomous University of Barcelona (UAB). That same year, his internship as an Internal Medicine specialist at the Vall d’Hebron University Hospital in Barcelona coincided with the first AIDS case reported in Spain. This case was the catalyst for a career dedicated to this serious disease, first as head of the HIV Unit of the Germans Trias i Pujol University Hospital in Badalona (1987-2015) and then as founder and president of the Fight against AIDS Foundation (1992), which is now named as Fight Infections Foundation.

Dr. Clotet soon saw the need to go a step beyond patient care to conduct research aimed at eradicating AIDS. In 1995, with the support of “la Caixa” and the Department of Health of the Generalitat of Catalonia, he founded the IrsiCaixa AIDS Research Institute, which he still heads. In addition, Dr. Clotet is also the clinical director of Infectious Diseases at the Metropolitana Nord area of the Catalan Institute of Health, scientific advisor to two IrsiCaixa spin-offs: Aelix Therapeutics SL and AlbaJuna Therapeutics SL and director of the Chair of AIDS and Related Diseases at the Universitat de Vic (UVic).

He has published more than 1000 papers in high impact international journals and his contributions to research have been recognized with the Josep Trueta medal to Sanitary Merit and the ‘Premi Nacional de Recerca’, among other awards.
Javier Martínez – Picado

Researcher and professor

ICREA, Irsicaixa AIDS Research Institute, Barcelona, Spain

Javier Martínez – Picado

Researcher and professor

ICREA Research Professor and Principal Investigator at Retrovirology and Clinical Studies research group, Irsicaixa AIDS Research Institute, Barcelona, Spain.

Accreditation

The activity has been accredited by the Comisión de Formación Continuada del Sistema Nacional de Salud and by the Consell Català de la Formació Continuada de les Professions Sanitàries with 0,4 credits and registered with number 09/026130-MD.